OTCMKTS:MRVFF Nuvo Pharmaceuticals (MRVFF) Stock Price, News & Analysis → A new way to collect income from stocks (From DTI) (Ad) Free MRVFF Stock Alerts $0.98 0.00 (0.00%) (As of 03/16/2023) Add Compare Share Share Today's Range$0.98▼$0.9850-Day Range$0.98▼$0.9852-Week Range$0.42▼$1.25VolumeN/AAverage Volume11,250 shsMarket Capitalization$11.17 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Nuvo Pharmaceuticals alerts: Email Address Ad DTIWhat is the 72-Hour Profit Surge?One of the most overlooked opportunities in the stock market is the 72-Hour Profit Surge... A short period of time where we can bet on a stock that is ALREADY “winning.” Let me give you a perfect example of how the Surge worked with Ross Stores. Back on November 16th, a little move was made that sent their stock soaring… The next day, my system would have alerted me that Ross Stores had entered the 72-Hour Profit Surge…Click here now to get all the details. About Nuvo Pharmaceuticals Stock (OTCMKTS:MRVFF)Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada.Read More MRVFF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MRVFF Stock News HeadlinesFebruary 2, 2024 | morningstar.comWest Pharmaceutical Services Inc WSTAugust 1, 2023 | seekingalpha.comNYMXF Nymox Pharmaceutical CorporationApril 26, 2024 | True Market Insiders (Ad)The “Next Bitcoin”? 10 CENT Crypto Set to ExplodeThe man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…March 10, 2023 | businesswire.comMiravo Healthcare™ Obtains Final Order Approving Plan of ArrangementFebruary 24, 2023 | seekingalpha.comMRVFF Nuvo Pharmaceuticals Inc.February 21, 2023 | finance.yahoo.comMiravo Healthcare™ Special Meeting ReminderOctober 31, 2022 | finance.yahoo.comMiravo Healthcare™ Announces Third Quarter 2022 Results Release Date and Conference Call DetailsAugust 2, 2022 | finance.yahoo.comMiravo Healthcare™ Announces Second Quarter 2022 Results Release Date and Conference Call DetailsApril 26, 2024 | DTI (Ad)My top 100 stocks…We recently ran an internal audit of every trade recommendation I’ve published across all my services… And let me tell ya, we found some incredible insights… For starters, we found about 100 stocks I trade really, really well.May 16, 2022 | finance.yahoo.comMiravo Healthcare™ Announces First Quarter 2022 ResultsMay 12, 2022 | stockhouse.comMiravo Healthcare(TM) Provides an Update on the United States Pennsaid® 2% BusinessMay 12, 2022 | finance.yahoo.comMiravo Healthcare™ Provides an Update on the United States Pennsaid® 2% BusinessMay 2, 2022 | stockhouse.comMiravo Healthcare(TM) Announces First Quarter 2022 Results Release Date and Virtual Annual Meeting of ShareholdersMay 2, 2022 | finance.yahoo.comMiravo Healthcare™ Announces First Quarter 2022 Results Release Date and Virtual Annual Meeting of ShareholdersApril 19, 2022 | finance.yahoo.comMiravo Healthcare™ to Present at Bloom Burton & Co. Healthcare Investor ConferenceMarch 29, 2022 | seekingalpha.comNuvo Pharmaceuticals; reports Q4 resultsMarch 28, 2022 | seekingalpha.comNuvo Pharmaceuticals Inc. 2021 Q4 - Results - Earnings Call PresentationMarch 28, 2022 | finance.yahoo.comMiravo Healthcare™ Announces 2021 and Fourth Quarter ResultsMarch 25, 2022 | stockhouse.comMiravo Healthcare(TM) Acknowledged In The Globe and Mail's Third-Annual Women Lead Here Benchmark of Executive Gender DiversityMarch 14, 2022 | finance.yahoo.comMiravo Healthcare™ Announces Fourth Quarter 2021 Results Release Date and Conference Call DetailsMarch 1, 2022 | finance.yahoo.comMiravo Healthcare™ Announces the Canadian Commercial Launch of Blexten® for Patients 4 Years of Age and Older*February 28, 2022 | stockhouse.comMiravo Healthcare(TM) Announces Summary Judgment Ruling by the United States District Court for the District of New JerseyFebruary 28, 2022 | finance.yahoo.comMiravo Healthcare™ Announces Summary Judgment Ruling by the United States District Court for the District of New JerseyFebruary 28, 2022 | finance.yahoo.comMiravo Healthcare(TM) to Present at Q1 Virtual Investor SummitJanuary 24, 2022 | finance.yahoo.comMiravo Healthcare™ Named to 2022 OTCQX Best 50January 18, 2022 | stockhouse.comMiravo Healthcare(TM) Announces Participation at the H.C. Wainwright Bioconnect ConferenceJanuary 6, 2022 | finance.yahoo.comMiravo Healthcare™ Announces Participation at the H.C. Wainwright Bioconnect ConferenceSee More Headlines Receive MRVFF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nuvo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:MRVFF CUSIPN/A CIKN/A Webwww.nuvopharmaceuticals.com Phone(905) 673-6980Fax905-673-1842Employees100Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.12) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-25,700,000.00 Net Margins20.88% Pretax Margin25.58% Return on Equity-1,996.22% Return on Assets14.25% Debt Debt-to-Equity Ratio9.97 Current Ratio2.11 Quick Ratio1.77 Sales & Book Value Annual Sales$54.98 million Price / Sales0.20 Cash Flow$0.09 per share Price / Cash Flow11.09 Book Value($0.80) per share Price / Book-1.22Miscellaneous Outstanding Shares11,400,000Free Float10,602,000Market Cap$11.17 million OptionableNot Optionable Beta0.98 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesJesse F. LedgerPresident & Chief Executive OfficerBernard ChiassonChief Scientific Officer & VP-OperationsMary-Jane E. BurkettChief Financial Officer & Vice PresidentWade HullVice President-Research & DevelopmentKatina K. LoucaidesSecretary, Vice President & General CounselKey CompetitorsMonopar TherapeuticsNASDAQ:MNPRAntibe TherapeuticsOTCMKTS:ATBPFEterna TherapeuticsNASDAQ:ERNAInhibitor TherapeuticsOTCMKTS:INTIGalera TherapeuticsNASDAQ:GRTXView All Competitors MRVFF Stock Analysis - Frequently Asked Questions How have MRVFF shares performed in 2024? Nuvo Pharmaceuticals' stock was trading at $0.9795 at the start of the year. Since then, MRVFF stock has increased by 0.0% and is now trading at $0.9795. View the best growth stocks for 2024 here. How do I buy shares of Nuvo Pharmaceuticals? Shares of MRVFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:MRVFF) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressThe only accurate crypto trading system I know …Weiss RatingsThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvo Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.